Parents
Sign in to add mentor| Steve Beckendorf | grad student | 2007 | UC Berkeley | |
| (Guidance and migration of the embryonic salivary glands in Drosophila melanogaster.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Buelow B, Avanzino B, Balasubramani A, et al. (2020) A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release. Journal of Clinical Oncology. 38: e18050-e18050 |
| Buelow B, Dang K, Dalvi P, et al. (2020) Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release. Journal of Clinical Oncology. 38: e17583-e17583 |
| Trinklein ND, Pham D, Schellenberger U, et al. (2019) Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. Mabs |
| Clarke S, Dang K, Li Y, et al. (2019) A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: 324-324 |
| Buelow B, Clarke S, Dang K, et al. (2019) Evaluation of monovalent versus biparatopic CD3xPSMA bispecific antibodies for t-cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: e16519-e16519 |
| Lorentsen K, Sankaran P, Trinklein ND, et al. (2019) Abstract 1554: Uncoupling tumor-cell cytotoxicity from cytokine release with novel T-cell engaging bispecific antibodies Cancer Research. 79: 1554-1554 |
| Buelow B, Choudhry P, Clarke S, et al. (2018) Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 60-60 |
| Force Aldred S, Boudreau A, Buelow B, et al. (2018) Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity. Journal of Clinical Oncology. 36: 57-57 |
| Rangaswamy U, Boudreau A, Buelow B, et al. (2018) A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release. Journal of Clinical Oncology. 36: 209-209 |
| Buelow B, Choudry P, Clarke S, et al. (2018) Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 8034-8034 |